Disorders of Body Water Homeostasis in Critical Illness (original) (raw)
2006, Endocrinology and Metabolism Clinics of North America
Disorders of sodium and water homeostasis are among the most commonly encountered disturbances in the critical care setting, because many disease states cause defects in the complex mechanisms that control the intake and output of water and solute. Because body water is the primary determinant of extracellular fluid osmolality, disorders of body water balance can be categorized into hypoosmolar and hyperosmolar disorders depending on the presence of an excess or a deficiency of body water relative to body solute. Because the main constituent of plasma osmolality is sodium, hypoosmolar and hyperosmolar disease states are generally characterized by hyponatremia and hypernatremia, respectively. Both of these disturbances, as well as their overly rapid correction, can cause considerable morbidity and mortality . After a brief review of normal water metabolism, this article focuses on the diagnosis and treatment of hyponatremia and hypernatremia in the critical care setting.
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Related papers
Hyponatremia and hypernatremia: disorders of water balance
The Journal of the Association of Physicians of India, 2009
Total body water and tonicity is tightly regulated by renal action of antidiuretic hormone (ADH), renin-angiotensinaldosterone system, norepinephrine and by the thirst mechanism. Abnormalities in water balance are manifested as sodium disturbances -hyponatremia and hypernatremia. Hyponatremia ([Na + <136meq/l]) is a common abnormality in hospitalized patients and is associated with increased morbidity and mortality. A common cause of hyponatremia is impaired renal water excretion either due to low extracellular fluid volume or inappropriate secretion of ADH. Clinical assessment of total body water and urine studies help in determining cause and guiding treatment of hyponatremia. Acute and severe hyponatremia cause neurological symptoms necessitating rapid correction with hypertonic saline. Careful administration and monitoring of serum [Na + ] is required to avoid overcorrection and complication of osmotic demyelination. Vasopressin receptor antagonists are being evaluated in management of euvolemic and hypervolemic hyponatremia. Hypernatremia ([Na + ]>145meq/l) is caused by primary water deficit (with or without Na + loss) and commonly occurs from inadequate access to water or impaired thirst mechanism. Assessment of the clinical circumstances and urine studies help determine the etiology, while management of hypernatremia involves fluid resuscitation and avoiding neurological complications from hypernatremia or its correction. Frequent monitoring of [Na + ] is of paramount importance in the treatment of sodium disorders that overcomes the limitations of prediction equations. ©
Virtually all investigators now agree that self-induced water intoxication, symptomatic hospital-acquired hyponatremia, and hyponatremia associated with intracranial pathology are true emergencies that demand prompt and definitive intervention with hypertonic saline. A 4-to 6-mmol/L increase in serum sodium concentration is adequate in the most seriously ill patients and this is best achieved with bolus infusions of 3% saline. Virtually all investigators now agree that overcorrection of hyponatremia (which we define as 10 mmol/L in 24 hours, 18 mmol/L in 48 hours, and 20 mmol/L in 72 hours) risks iatrogenic brain damage. Appropriate therapy should keep the patient safe from serious complications of hyponatremia while staying well clear of correction rates that risk iatrogenic injury. Accordingly, we suggest therapeutic goals of 6 to 8 mmol/L in 24 hours, 12 to 14 mmol/L in 48 hours, and 14 to 16 mmol/L in 72 hours. Inadvertent overcorrection owing to a water diuresis may complicate any form of therapy, including the newly available vasopressin antagonists. Frequent monitoring of the serum sodium concentration and urine output are mandatory. Administration of desmopressin to terminate an unwanted water diuresis is an effective strategy to avoid or reverse overcorrection. Semin Nephrol 29:282-299
Acute and Chronic Hyponatremia
Frontiers in Medicine, 2021
Hyponatremia is the most common electrolyte disorder in clinical practice. Catastrophic complications can occur from severe acute hyponatremia and from inappropriate management of acute and chronic hyponatremia. It is essential to define the hypotonic state associated with hyponatremia in order to plan therapy. Understanding cerebral defense mechanisms to hyponatremia are key factors to its manifestations and classification and subsequently to its management. Hypotonic hyponatremia is differentiated on the basis of urine osmolality, urine electrolytes and volume status and its treatment is decided based on chronicity and the presence or absence of central nervous (CNS) symptoms. Proper knowledge of sodium and water homeostasis is essential in individualizing therapeutic plans and avoid iatrogenic complications while managing this disorder.
A prospective study on clinical profile of hyponatremia in ICU hospitalized patients
The incidence of hyponatremia is roughly 12% in ICU hospitalized patients. The precise incidence of hyponatremia varies depending on the conditions leading to and the criteria used to define it. 1 Hyponatremia represents excess of body water relative to body sodium content and is frequently referred to as a serum sodium concentration of less than 135 mEq/L. Hyponatremia is the most common electrolyte disorder, 1 reported to occur in up to 6% of hospitalized patients. 3 Mild hyponatremia plasma sodium 130 -135 mmol / l ) is found in as many as 15 -30% of hospitalized patients or in the institutionalized elderly. 4 Clinically hyponatremia is often unrecognized when it is mild or when it develops slowly. But severe hyponatremia (plasma sodium < 120 mmol / l ), particularly of rapid onset, is associated with substantial morbidity and can be life threatening. 5 Also moderate to severe hyponatremia bears a substantial associated morbidity and mortality. Hyponatremia is associated with varying morbidity. Morbidity varies widely in severity; serious complications can arise from the disturbances itself as well as from the underlying causative conditions. Errors in assessment and management play to a significant extent. Hyponatremia is also an important predictor of mortality in heart failure 7 , cirrhosis 8 and acute pancreatitis. Unfortunately, hyponatremia is more often iatrogenic. Traditional therapies have significant limitations. Newer agents especially those that antagonize arginine vasopressin at V 2 receptor or both the V 1A and V 2 receptors show promise for treating hypervolemic and euvolemic hyponatremia, as they induce desired free water diuresis without inducing sodium excretion. Management of hyponatremia depends upon speed of recognition, its onset, magnitude and severity and associated risk factors especially for neurological complications.
Disturbances of Sodium in Critically Ill Adult Neurologic Patients
Journal of Neurosurgical Anesthesiology, 2006
Disorders of sodium and water balance are common in critically ill adult neurologic patients. Normal aspects of sodium and water regulation are reviewed. The etiology of possible causes of sodium disturbance is discussed in both the general inpatient and neurologic populations. Areas of importance are highlighted with regard to the differential diagnosis of sodium disturbance in neurologic patients and management strategies are discussed. Specific discussions of the etiology, diagnosis and management of cerebral salt wasting syndrome, the syndrome of inappropriate antidiuretic hormone secretion and central diabetes insipidus are presented, as well as the problems of over-treatment. The importance of diagnosis at an early stage of these diseases is stressed, with a recommendation for conservative management of milder cases.
Vasopressin Excess and Hyponatremia
American Journal of Kidney Diseases, 2006
is a common electrolyte disorder that frequently is overlooked and undertreated. Although the pathophysiological process of hyponatremia is complex, arginine vasopressin (AVP) is a common etiologic factor. Excess AVP release by osmotic or nonosmotic stimuli or both can lead to sodium and water imbalance. Conventional treatment options for hyponatremia, including water restriction and administration of sodium chloride with or without loop diuretics, do not directly address the underlying water retention induced by excess AVP in many cases. Clinical trials showed that AVP-receptor antagonists, including lixivaptan, tolvaptan, and conivaptan, produce aquaresis, the electrolyte-sparing excretion of free water, to correct serum sodium concentration. We review results from recent clinical trials involving AVP-receptor antagonists in the treatment of hyponatremia associated with AVP excess.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.